Dapagliflozin Helps Protect Kidneys from Cadmium Damage in Rats
Author Information
Author(s): Arab Hany H., Althobaiti Musaad M., Alharthi Abdulaziz S., Almalki Emad O., Alsoubie Saif S., Qattan Jawad M., Almalki Saeed A., Ashour Ahmed M., Eid Ahmed H.
Primary Institution: Taif University, Saudi Arabia
Hypothesis
Does dapagliflozin mitigate kidney injury caused by cadmium in rats?
Conclusion
Dapagliflozin significantly reduces kidney damage caused by cadmium by enhancing antioxidant pathways and promoting autophagy.
Supporting Evidence
- Dapagliflozin reduced serum creatinine and urea levels in cadmium-treated rats.
- Histopathological analysis showed less kidney damage in dapagliflozin-treated rats.
- Dapagliflozin improved antioxidant levels and reduced oxidative stress markers.
- The treatment enhanced autophagy and reduced apoptosis in kidney cells.
Takeaway
Dapagliflozin is like a superhero for rat kidneys, helping them fight off bad stuff from cadmium and keeping them healthy.
Methodology
The study involved administering cadmium to rats and then treating them with dapagliflozin, followed by various biochemical and histopathological analyses.
Limitations
The study was conducted only in rats, and further research is needed to confirm findings in humans.
Participant Demographics
Wistar albino rats, 180-220 g, 8-10 weeks old.
Statistical Information
P-Value
p<0.001
Statistical Significance
p<0.001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website